Merus (MRUS) Stock Forecast, Price Target & Predictions
MRUS Stock Forecast
Merus stock forecast is as follows: an average price target of $81.25 (represents a 94.15% upside from MRUS’s last price of $41.85) and a rating consensus of 'Buy', based on 10 wall street analysts offering a 1-year stock forecast.
MRUS Price Target
MRUS Analyst Ratings
Buy
Merus Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 02, 2024 | Etzer Darout | BMO Capital | $95.00 | $48.53 | 95.76% | 127.00% |
Nov 21, 2024 | Richard Law | Goldman Sachs | $73.00 | $50.74 | 43.87% | 74.43% |
Oct 24, 2024 | David Dai | UBS | $72.00 | $52.31 | 37.64% | 72.04% |
Aug 05, 2024 | Ami Fadia | Needham | $85.00 | $50.14 | 69.53% | 103.11% |
Jun 17, 2024 | Bradley Canino | Stifel Nicolaus | $99.00 | $56.55 | 75.07% | 136.56% |
Jun 04, 2024 | Asthika Goonewardene | Truist Financial | $88.00 | $52.94 | 66.23% | 110.27% |
Jun 04, 2024 | Etzer Darout | BMO Capital | $91.00 | $52.94 | 71.89% | 117.44% |
Jun 04, 2024 | John Newman | Canaccord Genuity | $67.00 | $52.94 | 26.56% | 60.10% |
May 29, 2024 | Andrew Fein | H.C. Wainwright | $85.00 | $54.87 | 54.91% | 103.11% |
May 28, 2024 | Etzer Darout | BMO Capital | $84.00 | $53.86 | 55.96% | 100.72% |
May 28, 2024 | Bradley Canino | Stifel Nicolaus | $90.00 | $54.80 | 64.23% | 115.05% |
May 24, 2024 | Asthika Goonewardene | Truist Financial | $69.00 | $60.99 | 13.13% | 64.87% |
May 24, 2024 | Etzer Darout | BMO Capital | $58.00 | $58.60 | -1.03% | 38.59% |
Nov 16, 2022 | Citigroup | $30.00 | $18.25 | 64.38% | -28.32% |
Merus Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 2 | 3 | 13 |
Avg Price Target | $84.00 | $80.00 | $81.23 |
Last Closing Price | $41.85 | $41.85 | $41.85 |
Upside/Downside | 100.72% | 91.16% | 94.10% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 02, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Nov 21, 2024 | Goldman Sachs | Buy | Initialise | |
Oct 24, 2024 | UBS | Buy | Initialise | |
Oct 01, 2024 | Guggenheim | Buy | Buy | Hold |
Aug 05, 2024 | Needham | Buy | Buy | Hold |
Jun 26, 2024 | Citigroup | Buy | Buy | Hold |
May 29, 2024 | Bank of America Securities | Buy | Buy | Hold |
May 28, 2024 | Citigroup | Buy | Buy | Hold |
May 28, 2024 | Needham | Buy | Buy | Hold |
May 24, 2024 | Cowen & Co. | Buy | Buy | Hold |
May 24, 2024 | BMO Capital | Outperform | Outperform | Hold |
May 24, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Apr 18, 2023 | Needham | Buy | Buy | Hold |
Nov 16, 2022 | Citigroup | Buy | Buy | Hold |
Oct 13, 2022 | SVB Leerink | Outperform | Outperform | Hold |
Merus Financial Forecast
Merus Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $11.03M | $10.48M | $13.50M | $10.67M | $6.58M | $12.68M | $11.65M | $14.71M | $13.67M | $12.38M | $8.35M | $9.02M | $8.57M | $6.06M | $6.30M | $7.51M | - |
Avg Forecast | $1.28M | $1.08M | $899.75K | $814.38K | $12.41M | $10.64M | $13.03M | $9.21M | $9.26M | $8.67M | $8.72M | $9.59M | $9.60M | $9.92M | $10.78M | $11.29M | $9.70M | $11.00M | $10.62M | $9.37M | $11.81M | $13.14M | $8.06M | $18.05M | $7.57M | $7.45M | $7.51M | $8.53M | $7.39M | $7.86M |
High Forecast | $2.46M | $2.07M | $1.73M | $1.56M | $23.80M | $20.41M | $24.98M | $10.78M | $24.99M | $8.96M | $9.01M | $18.39M | $11.97M | $10.21M | $20.67M | $21.65M | $18.60M | $11.00M | $10.62M | $9.37M | $11.81M | $13.14M | $8.06M | $18.05M | $7.57M | $7.45M | $7.51M | $8.53M | $7.39M | $7.86M |
Low Forecast | $792.62K | $667.38K | $555.77K | $503.04K | $7.67M | $6.58M | $8.05M | $8.32M | $3.15M | $8.39M | $8.42M | $5.92M | $7.39M | $9.63M | $6.66M | $6.97M | $5.99M | $11.00M | $10.62M | $9.37M | $11.81M | $13.14M | $8.06M | $18.05M | $7.57M | $7.45M | $7.51M | $8.53M | $7.39M | $7.86M |
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 11 | 5 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 9 | 10 | 11 | 15 | 9 | 9 | 8 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 0.97% | 1.20% | 1.10% | 0.60% | 1.19% | 1.24% | 1.25% | 1.04% | 1.54% | 0.46% | 1.19% | 1.15% | 0.81% | 0.74% | 1.02% | - |
Forecast
Merus EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 11 | 5 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 9 | 10 | 11 | 15 | 9 | 9 | 8 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-21.89M | $-30.54M | $-30.72M | $-24.00M | $-70.94M | $-55.39M | $-34.45M | $-13.93M | $-14.48M | $-26.94M | $-9.71M | $-27.36M | $-22.53M | $-17.60M | $-16.08M | $-26.82M | - |
Avg Forecast | $-1.28M | $-1.08M | $-899.75K | $-814.38K | $-12.41M | $-10.64M | $-13.03M | $-9.21M | $-9.26M | $-8.67M | $-8.72M | $-28.96M | $-9.60M | $-9.92M | $-10.78M | $-26.33M | $-20.02M | $-11.00M | $-10.62M | $-23.94M | $-11.81M | $-13.14M | $-8.06M | $-8.09M | $-7.57M | $-7.45M | $-7.51M | $-12.98M | $-7.39M | $-7.86M |
High Forecast | $-792.62K | $-667.38K | $-555.77K | $-503.04K | $-7.67M | $-6.58M | $-8.05M | $-8.32M | $-3.15M | $-8.39M | $-8.42M | $-23.17M | $-7.39M | $-9.63M | $-6.66M | $-21.06M | $-16.02M | $-11.00M | $-10.62M | $-19.15M | $-11.81M | $-13.14M | $-8.06M | $-6.47M | $-7.57M | $-7.45M | $-7.51M | $-10.38M | $-7.39M | $-7.86M |
Low Forecast | $-2.46M | $-2.07M | $-1.73M | $-1.56M | $-23.80M | $-20.41M | $-24.98M | $-10.78M | $-24.99M | $-8.96M | $-9.01M | $-34.76M | $-11.97M | $-10.21M | $-20.67M | $-31.60M | $-24.03M | $-11.00M | $-10.62M | $-28.72M | $-11.81M | $-13.14M | $-8.06M | $-9.71M | $-7.57M | $-7.45M | $-7.51M | $-15.57M | $-7.39M | $-7.86M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.21% | 2.83% | 1.17% | 1.20% | 6.45% | 5.22% | 1.44% | 1.18% | 1.10% | 3.34% | 1.20% | 3.62% | 3.02% | 2.34% | 1.24% | 3.63% | - |
Forecast
Merus Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 11 | 5 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 9 | 10 | 11 | 15 | 9 | 9 | 8 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-23.01M | $-32.03M | $-39.74M | $-81.97M | $-24.61M | $-5.71M | $-18.89M | $-14.42M | $-14.85M | $-27.39M | $-10.15M | $-27.96M | $-23.07M | $-17.97M | $-16.50M | $-26.14M | - |
Avg Forecast | $-60.26M | $-58.92M | $-61.07M | $-68.57M | $-64.74M | $-62.85M | $-63.42M | $-60.73M | $-59.66M | $-52.56M | $-48.30M | $-29.87M | $-48.45M | $-49.06M | $-52.84M | $-27.15M | $-20.72M | $-38.71M | $-36.48M | $-24.68M | $-34.06M | $-32.80M | $-31.10M | $-8.46M | $-31.97M | $-29.13M | $-32.75M | $-13.32M | $-29.91M | $-29.78M |
High Forecast | $-30.31M | $-29.64M | $-30.72M | $-34.49M | $-32.56M | $-31.61M | $-31.90M | $-54.54M | $-48.33M | $-26.44M | $-24.30M | $-23.89M | $-33.44M | $-24.68M | $-26.58M | $-21.72M | $-16.58M | $-38.71M | $-36.48M | $-19.75M | $-34.06M | $-32.80M | $-31.10M | $-6.77M | $-31.97M | $-29.13M | $-32.75M | $-10.65M | $-29.91M | $-29.78M |
Low Forecast | $-132.14M | $-129.20M | $-133.91M | $-150.36M | $-141.97M | $-137.82M | $-139.07M | $-69.16M | $-81.74M | $-115.27M | $-105.92M | $-35.84M | $-68.24M | $-107.59M | $-115.88M | $-32.58M | $-24.87M | $-38.71M | $-36.48M | $-29.62M | $-34.06M | $-32.80M | $-31.10M | $-10.15M | $-31.97M | $-29.13M | $-32.75M | $-15.98M | $-29.91M | $-29.78M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.47% | 0.61% | 1.46% | 3.96% | 0.64% | 0.16% | 0.77% | 0.42% | 0.45% | 0.88% | 1.20% | 0.87% | 0.79% | 0.55% | 1.24% | 0.87% | - |
Forecast
Merus SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 11 | 5 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 9 | 10 | 11 | 15 | 9 | 9 | 8 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.59M | $16.06M | $15.39M | $15.28M | $12.47M | $12.70M | $11.75M | $10.82M | $10.17M | $10.57M | $9.33M | $9.72M | $9.14M | $8.04M | $8.88M | $12.00M | - |
Avg Forecast | $1.47M | $1.24M | $1.03M | $934.94K | $14.25M | $12.22M | $14.96M | $10.57M | $10.64M | $9.96M | $10.01M | $11.01M | $11.02M | $11.39M | $12.37M | $12.96M | $11.14M | $12.50M | $12.06M | $10.64M | $13.42M | $14.94M | $9.16M | $7.78M | $8.60M | $8.47M | $8.54M | $7.17M | $8.40M | $8.93M |
High Forecast | $2.82M | $2.38M | $1.98M | $1.79M | $27.33M | $23.43M | $28.68M | $12.38M | $28.68M | $10.29M | $10.35M | $21.11M | $13.74M | $11.72M | $23.73M | $24.86M | $21.36M | $12.50M | $12.06M | $10.64M | $13.42M | $14.94M | $9.16M | $9.33M | $8.60M | $8.47M | $8.54M | $8.60M | $8.40M | $8.93M |
Low Forecast | $909.96K | $766.17K | $638.04K | $577.50K | $8.80M | $7.55M | $9.24M | $9.56M | $3.62M | $9.63M | $9.67M | $6.80M | $8.49M | $11.05M | $7.64M | $8.01M | $6.88M | $12.50M | $12.06M | $10.64M | $13.42M | $14.94M | $9.16M | $6.22M | $8.60M | $8.47M | $8.54M | $5.73M | $8.40M | $8.93M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.30% | 1.19% | 1.37% | 1.00% | 1.05% | 1.10% | 0.81% | 0.68% | 1.15% | 1.20% | 1.13% | 1.08% | 0.94% | 1.24% | 1.43% | - |
Forecast
Merus EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 5 | 11 | 5 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 9 | 10 | 11 | 15 | 9 | 9 | 8 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.43 | $-0.66 | $-0.86 | $-2.12 | $-0.53 | $-0.13 | $-0.43 | $-0.46 | $-0.39 | $-0.71 | $-0.28 | $-0.96 | $-0.64 | $-0.54 | $-0.68 | $-1.12 | - |
Avg Forecast | $-0.88 | $-0.86 | $-0.89 | $-1.00 | $-0.95 | $-0.92 | $-0.93 | $-0.89 | $-0.87 | $-0.77 | $-0.71 | $-0.75 | $-0.71 | $-0.72 | $-0.77 | $-0.94 | $-0.88 | $-0.63 | $-0.59 | $-0.56 | $-0.55 | $-0.53 | $-0.50 | $-0.20 | $-0.52 | $-0.47 | $-0.53 | $-0.51 | $-0.48 | $-0.48 |
High Forecast | $-0.44 | $-0.43 | $-0.45 | $-0.51 | $-0.48 | $-0.46 | $-0.47 | $-0.80 | $-0.71 | $-0.39 | $-0.36 | $-0.38 | $-0.49 | $-0.36 | $-0.39 | $-0.47 | $-0.44 | $-0.63 | $-0.59 | $-0.56 | $-0.55 | $-0.53 | $-0.50 | $-0.20 | $-0.52 | $-0.47 | $-0.53 | $-0.51 | $-0.48 | $-0.48 |
Low Forecast | $-1.94 | $-1.89 | $-1.96 | $-2.20 | $-2.08 | $-2.02 | $-2.04 | $-1.01 | $-1.20 | $-1.69 | $-1.55 | $-1.64 | $-1.00 | $-1.58 | $-1.70 | $-2.05 | $-1.93 | $-0.63 | $-0.59 | $-0.56 | $-0.55 | $-0.53 | $-0.50 | $-0.20 | $-0.52 | $-0.47 | $-0.53 | $-0.51 | $-0.48 | $-0.48 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.60% | 0.85% | 0.92% | 2.41% | 0.85% | 0.22% | 0.77% | 0.84% | 0.74% | 1.41% | 1.37% | 1.86% | 1.36% | 1.02% | 1.32% | 2.31% | - |
Forecast
Merus Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
STRO | Sutro Biopharma | $2.09 | $13.00 | 522.01% | Buy |
ANEB | Anebulo Pharmaceuticals | $1.31 | $6.00 | 358.02% | Buy |
LRMR | Larimar Therapeutics | $4.32 | $17.00 | 293.52% | Buy |
ACRV | Acrivon Therapeutics | $7.21 | $22.50 | 212.07% | Buy |
ANAB | AnaptysBio | $15.99 | $49.83 | 211.63% | Buy |
MLYS | Mineralys Therapeutics | $12.35 | $30.00 | 142.91% | Buy |
KURA | Kura Oncology | $9.74 | $23.33 | 139.53% | Buy |
ADAG | Adagene | $2.10 | $5.00 | 138.10% | Buy |
SNDX | Syndax Pharmaceuticals | $13.63 | $31.67 | 132.36% | Buy |
MRUS | Merus | $44.90 | $81.25 | 80.96% | Buy |
PCVX | Vaxcyte | $89.86 | $148.80 | 65.59% | Buy |
REPL | Replimune Group | $11.72 | $19.00 | 62.12% | Buy |
LYEL | Lyell Immunopharma | $0.65 | $1.00 | 53.85% | Hold |
PTGX | Protagonist Therapeutics | $40.69 | $57.33 | 40.89% | Buy |
CRNX | Crinetics Pharmaceuticals | $55.37 | $69.00 | 24.62% | Buy |
KRON | Kronos Bio | $0.96 | $1.00 | 4.17% | Buy |